New MRI technique could unlock secrets of pelvic vein disorders

NCT ID NCT06888024

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study uses special MRI scans to measure blood flow in the pelvic veins of 15 people. It includes three groups: healthy volunteers, people with May-Thurner syndrome (a compressed vein), and those who have had a stent placed. The goal is to create a detailed understanding of normal and abnormal blood flow, which could improve future diagnosis and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better diagnose and treat pelvic vein compression conditions like May-Thurner syndrome.

What could go wrong

This is a very small, early imaging study with only 15 participants, so results may not apply to everyone. It is not testing a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAY-THURNER SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Massachusetts

    RECRUITING

    Worcester, Massachusetts, 01655, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.